Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer

Laryngoscope

Volumn 119, Issue 10, 2009, Pages 1958-1965

  Hwang, Harry S ^a   Perez, Daniel A ^a   Orloff, Lisa A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Computed tomography; Head; Neck cancer; PET CT; Positron emission tomography; Thyroid cancer; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID CANCER;

BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS;

EID: 70349939561     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20594     Document Type: Article

References (36)

1. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 1996;156:2165-2172.
2. Ogilvie JB, Piatigorsky EJ, Clark OH. Current status for fine needle aspiration for thyroid nodules. Adv Surg 2006;40:223-238.
3. Hegedus L, Bonnema SJ, Bennedbaek FN. Management ofsimple nodular goiter: current status and future perspectives.Endocr Rev 2003;24:102-132.
4. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 2001;154:1838-1840.
5. Bogsrud TV, Karantanis D, Nathan MA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nuclear Med Commun 2007;28:373-381.
6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
7. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006.CA Cancer J Clin 2006;56:106-130.
8. Jessup JM, Menck HR, Winchester DP, Hundahl SA, Murphy GP. The National Cancer Data Base report on patterns of hospital reporting. Cancer 1996;78:1829-1837.
9. Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA. The role of positron emission tomography scans in the management of the N-positive neck in headand neck squamous cell carcinoma after chemotherapy. Laryngoscope 2006;116:855-858.
10. Tan A, Adelstein DJ, Rybicki LA, et al. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2007;133:435-440.
11. Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18Ffluordeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005;25:1421-1426.
12. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk ofcancer of focal thyroid incidentaloma identified by 18Ffluorodeoxyglucose positron emission tomography for metastasise valuation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88:4100-4104.
13. Jeong HS, Baek CH, Son YI, et al. Integrated 18F-FDGPET/CT for the initial evaluation of cervical node level ofpatients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clin Endocrinol (Oxf) 2006;65:402-407.
14. Shammas A, Degirmenci B, Mountz JM, et al. 18F-FDGPET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 2007;48:221-226. Erratum in: J Nucl Med 2007;48:412.
15. Peccin S, de Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? J EndocrinolInvest 2002;25:39-43.
16. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thethyroid: an appraisal. Ann Intern Med 1993;118:282-289.
17. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine needle aspiration biopsy of thyroidnodules. Thyroid 1998;8:15-21.
18. Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. Theimpact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid 2006;16:55-60.
19. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA. Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci 1982;7:185-192.
20. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;110(3 pt 1):397-401.
21. Sato N, Oyamatsu M, Koyama Y, Emura I, Tamiya Y, Hatakeyama K. Do the level of nodal disease according to the TNM classification and the number of involved cervicalnodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 1998;69:151-155.
22. Prayer L, Winkelbauer H, Gritzmann N, Winkelbauer F,Helmer M, Pehamberger H. Sonography versus palpationin the detection of regional lymph-node metastases inpatients with malignant melanoma. Eur J Cancer 1990;26:827-830.
23. van den Brekel MW, Castelijns JA, Stel HV, Golding RP,Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11-17.
24. Vassallo P, Edel G, Roos N, Naguib A, Peters PE. In vitrohigh-resolution ultrasonography of benign and malignant lymph nodes, a sonographic-pathologic correlation. Inves Radiol 1993;28:698-705.
25. van den Brekel MW, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and USguided fine-needle aspiration cytology. Radiology 1991;180:457-461.
26. Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H,Muller-Schauenburg W. Fluorine-18-FDG and Iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37:1468-1472.
27. Feine U. Fluoro-18-deoxyglucose positron emission tomographyin differentiated thyroid carcinoma. Eur J Endocrinol 1998;138:492-496.
28. Grunwald F, Schomburg A, Bender H, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 1996;23:312-319.
29. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002;225:575-581.
30. Palmedo H, Bucerius J, Joe A, et al. Integrated PET/CT indifferentiated thyroid cancer, diagnostic accuracy andimpact on patient management. J Nucl Med 2006;47:616-624.
31. Schwartz DL, Rajendran J, Yueh B, et al. Staging of head and neck squamous cell cancer with extended field FDG-PET. Arch Otolaryngol Head Neck Surg 2003;129:1173-1178.
32. Sisson JC, Ackermann RJ, Meyer MA, Wahl RL. Uptake of 18-fluoro-2-deoxy-Dglucose by thyroid cancer: implicationsfor diagnosis and therapy. J Clin Endocrinol Metab 1993;77:1090-1094.
33. Keyes JW Jr, Harkness BA, Greven KM, Williams DW III,Watson NE Jr, McGuirt WF. Salivary gland tumours: pretherapy evaluation with PET. Radiology 1994;192:99-102.
34. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomographyin patients with head and neck cancer. Laryngoscope 1999;109:880-885.
35. Yao M, Luo P, Hoffman HT, et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clinc Oncol 2007;30:264-270.
36. Ryan WR, Fee WE Jr, Le QT, Pinto HA. Positron-emissiontomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645-650